Heal the World for a Better Life

HK inno.N, a leading pharmaceutical firm of Korea, plays a key role in the HK Kolmar Group. The company has been investing in its R&D capabilities to develop novel drugs for to treat digestive system, cancer and immune diseases, as well as vaccines and treatments for infection. HK inno.N has been contributing to the innovation in the latestbio-pharmaceuticals bio-healthcare by combining technologies of the 4th industrial revolution with.